Journal of Clinical Immunology and Cellular Therapy

About Journal

Journal of Clinical Immunology and Cellular Therapy (JCICT) is an open access, peer reviewed journal that publishes articles related to basic, clinical, translational, cellular and molecular immunology.

Immunology is a branch of biomedical science which deals with an organism’s response towards an invading environmental factor. This process involves a complex interplay of invading particle and defence system of the host organism along with successive cascading molecular mechanism to eliminate the invading agent.

Aim and Scope

JCICT journal publishes quality research articles, mini-communications, reviews, reports, case studies, clinical surveys, editorials, etc., related to all aspects of Immunology Research. Through this JCICT journal platform we hope to serve the international community of students, researchers, academicians and other professionals in enlightening the recent trends in emerging fields of clinical immunology.

JCICT journal scope includes various topics but not limited to clinical and cellular Immunological aspects such as systemic lupus erythmatosus, cancer immunology, tumor biology, macrophage polarization, transplantation immunology, innate immunology, adaptive immunity, cellular & molecular immunology, vaccine development, signal transduction, innate immunity, cancer Immunotherapy, inflammatory disorders, medical immunology, diagnostic immunology, clinical immunology, HIV immunology, allergy & immunology, immunomodulation, multiple sclerosis,neuroinflammatory diseases, clinical & vaccine immunology, clinical experimental immunology, T-cell immunology, autoimmune diseases, hypersensitivities, immune deficiency, transplant rejection), the physical, chemical and physiological characteristics of the components of the immune system in vitro, in situ, and in vivo studies.

Editorial Managing Policy

JCICT is using Editorial Manager Policy to attain quality in review process. This Policy follows an online manuscript submission, review and tracking systems. Review processing is performed by journal editorial board members or by outside experts. Editorial Managing Policy simplifies the publication process and helps the author to get track of their articles. 

JCICT Open Access

As JCICT is an International Open Access journal, all the articles published under this journal will be accessible to all internet users throughout the world without any barrier of access under the terms of the Creative Commons Attribution License. All published articles will be assigned DOI provided by Cross Ref.  JCICT will keep up-to- date with the latest advancements in the fields of Clinical Immunology. Abstracts and Pdfs of all articles published are freely available to all interested online readers immediately after publication without any restrictions or any other subscriptions to researchers worldwide.

Authors are welcome to submit the manuscript through our online portal and or send us an E-mail attachment to our Editorial Office.


Journal Highlights

  • Carcinogenesis
  • Cancer Immunotherapy
  • Cell based Immunotherapy
  • Chemo Immunotherapy
  • Radio Immunotherapy
  • Immunotherapeutic agents
  • Restorative Immunotherapy
  • Translational Immunotherapy
  • Immunity Enhancers
  • Cancer
  • Immunology
  • Immune System
  • Immunogenetics
  • Immunopharmacology
  • Osteoimmunology
  • Neuroimmunology
  • Diagnostic Immunology
  • Autoimmune diseases
  • Adaptive Immune System
  • Pathogens
  • Cellular Immunotherapy
  • Tumour Immunology
  • Immunotherapy Biomarkers
  • Passive Immunity
  • Active Immunity
  • Antibody Regulation
  • Antigen
  • Infection
  • Inflammation
  • Acute Inflammation
  • Chronic Inflammation
  • Diagnostic Immunology
  • Class, I MHC molecules
  • Class II MHC molecule
  • Colitis Antibiotics
  • Immune response
  • Immunochemistry
  • Immunogenicity of biopharmaceuticals
  • Immunomodulatoryxenobiotics
  • Immunopharmacology